Decision over routine PSA testing is due at end of this month, though some feel the supporting data is unclear Decision over routine PSA testing is due at end of this month, though some feel the supporting data is unclear J unior Hemans was having a routine health check in 2014 when he was diagnosed with prostate cancer, at the age of 51. He knew there was an increased risk of the disease in black men so asked to have a prostate specific antigen (PSA) test, which was not initially included. “